よむ、つかう、まなぶ。
09 参考資料 2－1 肺炎球菌コンジュゲートワクチン（小児用）ファクトシート［1.2MB］ (13 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_34803.html |
| 出典情報 | 厚生科学審議会 予防接種・ワクチン分科会 予防接種基本方針部会 ワクチン評価に関する小委員会（第20回 8／29）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
床疫学的検討．日本小児科学会雑誌 112:973-980, 2008.
6. Black S et al.: Efficacy, safety and immunogenicity of heptavalent
pneumococcal conjugate vaccine in children. Pediatr Infect Dis J
19:187-195, 2000.
7. Pilishvili T et al.: Sustained reductions in invasive pneumococcal
disease in era of conjugate vaccine. J Infect Dis 201:32-41, 2010.
8. Roche PW et al.: Invasive pneumococcal disease in Australia, 2006. Commun
Dis Intell 32:18-30, 2008.
9. Kellner JD et al.: Changing epidemiology of invasive pneumococcal
disease in Canada, 1998-2007: update from Calgary-area Streptococcus
pneumoniae research (CASPER) study. Clin Infect Dis 49:205-212, 2009.
10. Lepoutre A et al.: Impact of infant pneumococcal vaccination on invasive
pneumococcal diseases in France, 2001-2006. Euro Surveill 28:13, 2008.
11. Rükinger S et al.: Reduction in the incidence of invasive pneumococcal
disease after general vaccination with 7-valent pneumococcal conjugate
vaccine in Germany. Vaccine 27:4136-4141, 2009.
12. Vestrheim DF et al.: Effectiveness of a 2+1 dose schedule pneumococcal
conjugate vaccination programme on invasive pneumococcal disease among
children in Norway. Vaccine 26:3277-3281, 2008.
13. Black SB et al.: Effectiveness of heptavalent pnuemococcal conjugate
vaccine in children younger than five years of age for prevention
pneumonia. Pediatr Infect Dis J 21:810-815, 2002.
14. Fireman B et al.: Impact of the pneumococcal conjugate vaccine on otitis
media. Pediatr Infect Dis J 22:10-16, 2003.
15. Eskola J et al.: Efficacy of a pneumococcal conjugate vaccine against
acute otitis media. N Engl J Med 344:403-409,2001.
16. Grijalva CG et al.: Decline in pneumonia admissions after routine
childhood immunization with pneumococcal conjugate vaccine in the USA:
a time-series analysis. Lancet 369:1179-1186, 2007.
17. 神谷 齊ほか:小児用７価肺炎球菌結合型ワクチンの医療経済効果: 小児
科臨床 61:84-94, 2008.
18. 石和田 稔彦ほか: インフルエンザ菌、肺炎球菌全身感染症罹患状況(2007
－2009) 日本小児科学会雑誌
12
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
床疫学的検討．日本小児科学会雑誌 112:973-980, 2008.
6. Black S et al.: Efficacy, safety and immunogenicity of heptavalent
pneumococcal conjugate vaccine in children. Pediatr Infect Dis J
19:187-195, 2000.
7. Pilishvili T et al.: Sustained reductions in invasive pneumococcal
disease in era of conjugate vaccine. J Infect Dis 201:32-41, 2010.
8. Roche PW et al.: Invasive pneumococcal disease in Australia, 2006. Commun
Dis Intell 32:18-30, 2008.
9. Kellner JD et al.: Changing epidemiology of invasive pneumococcal
disease in Canada, 1998-2007: update from Calgary-area Streptococcus
pneumoniae research (CASPER) study. Clin Infect Dis 49:205-212, 2009.
10. Lepoutre A et al.: Impact of infant pneumococcal vaccination on invasive
pneumococcal diseases in France, 2001-2006. Euro Surveill 28:13, 2008.
11. Rükinger S et al.: Reduction in the incidence of invasive pneumococcal
disease after general vaccination with 7-valent pneumococcal conjugate
vaccine in Germany. Vaccine 27:4136-4141, 2009.
12. Vestrheim DF et al.: Effectiveness of a 2+1 dose schedule pneumococcal
conjugate vaccination programme on invasive pneumococcal disease among
children in Norway. Vaccine 26:3277-3281, 2008.
13. Black SB et al.: Effectiveness of heptavalent pnuemococcal conjugate
vaccine in children younger than five years of age for prevention
pneumonia. Pediatr Infect Dis J 21:810-815, 2002.
14. Fireman B et al.: Impact of the pneumococcal conjugate vaccine on otitis
media. Pediatr Infect Dis J 22:10-16, 2003.
15. Eskola J et al.: Efficacy of a pneumococcal conjugate vaccine against
acute otitis media. N Engl J Med 344:403-409,2001.
16. Grijalva CG et al.: Decline in pneumonia admissions after routine
childhood immunization with pneumococcal conjugate vaccine in the USA:
a time-series analysis. Lancet 369:1179-1186, 2007.
17. 神谷 齊ほか:小児用７価肺炎球菌結合型ワクチンの医療経済効果: 小児
科臨床 61:84-94, 2008.
18. 石和田 稔彦ほか: インフルエンザ菌、肺炎球菌全身感染症罹患状況(2007
－2009) 日本小児科学会雑誌
12